CATALOGO DEI PRODOTTI DELLA RICERCA

BENCIVENGA, Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.084
NA - Nord America 3.165
AS - Asia 2.608
SA - Sud America 440
AF - Africa 106
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 10.419
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.088
RU - Federazione Russa 2.064
SG - Singapore 1.042
CN - Cina 794
GB - Regno Unito 528
BR - Brasile 357
IT - Italia 352
HK - Hong Kong 260
SE - Svezia 222
IE - Irlanda 218
VN - Vietnam 210
DE - Germania 204
FR - Francia 170
FI - Finlandia 111
KR - Corea 85
JP - Giappone 53
UA - Ucraina 44
CA - Canada 43
ES - Italia 40
AR - Argentina 35
AT - Austria 31
ID - Indonesia 31
NL - Olanda 27
TG - Togo 24
MX - Messico 22
IN - India 21
RW - Ruanda 21
BJ - Benin 20
BD - Bangladesh 19
IL - Israele 17
ZA - Sudafrica 16
BE - Belgio 15
PL - Polonia 15
TR - Turchia 13
EC - Ecuador 12
AU - Australia 9
LT - Lituania 9
PY - Paraguay 9
IQ - Iraq 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
CO - Colombia 7
PT - Portogallo 7
TW - Taiwan 7
JO - Giordania 5
KG - Kirghizistan 5
PE - Perù 5
AZ - Azerbaigian 4
DZ - Algeria 4
MA - Marocco 4
UY - Uruguay 4
AL - Albania 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
GR - Grecia 3
HN - Honduras 3
LK - Sri Lanka 3
NO - Norvegia 3
PK - Pakistan 3
TH - Thailandia 3
TN - Tunisia 3
VE - Venezuela 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
CH - Svizzera 2
CR - Costa Rica 2
HU - Ungheria 2
IR - Iran 2
KE - Kenya 2
LU - Lussemburgo 2
LV - Lettonia 2
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CM - Camerun 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
MK - Macedonia 1
MR - Mauritania 1
MU - Mauritius 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 10.419
Salva come PNG Salva come JPEG
Città #
Moscow 697
Singapore 437
Southend 413
Chandler 407
Dallas 380
Ashburn 324
Hong Kong 258
Dublin 214
Beijing 162
Jacksonville 156
Verona 156
New York 121
Los Angeles 108
Ann Arbor 93
The Dalles 82
Redmond 78
Ho Chi Minh City 74
Woodbridge 74
Munich 69
Houston 65
Lawrence 62
Princeton 62
Helsinki 58
Jinan 56
Tokyo 49
Wilmington 48
Nanjing 42
São Paulo 40
Shenyang 38
London 33
Redondo Beach 33
Columbus 32
Hanoi 30
Seoul 30
Buffalo 29
Hebei 27
Santa Clara 27
Sindelfingen 27
Dong Ket 24
Lomé 24
Tianjin 24
Milan 22
Jakarta 21
Kigali 21
Changsha 20
Cotonou 20
Atlanta 19
Guangzhou 19
Amsterdam 18
Brooklyn 18
Vienna 18
Haikou 17
Seattle 17
Falls Church 16
Brussels 15
Denver 15
Nanchang 15
San Francisco 15
Turku 15
Frankfurt am Main 14
Lappeenranta 14
Ningbo 14
Nuremberg 14
Taizhou 14
Zhengzhou 14
Council Bluffs 13
Orem 13
Stockholm 13
Chicago 12
Hangzhou 12
Montreal 12
Washington 12
Jiaxing 11
Madrid 11
Manchester 11
Warsaw 11
Belo Horizonte 10
Boston 10
Chennai 10
Mexico City 10
Toronto 10
Fuzhou 9
Phoenix 9
Poplar 9
Boardman 8
Falkenstein 8
Redwood City 8
Rio de Janeiro 8
Ankara 7
Bologna 7
Brasília 7
Haiphong 7
Johannesburg 7
Auburn Hills 6
Curitiba 6
Erba 6
Goiânia 6
Guayaquil 6
Lancaster 6
Norwalk 6
Totale 5.885
Salva come PNG Salva come JPEG
Nome #
Genomic characterization of hepatoid tumors: context matters 229
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 209
Proton Magnetic Resonance Spectroscopy: Ex vivo study to investigate its prognostic role in colorectal cancer. 190
Shape and volume of internal anal sphincter showed by three-dimensional anorectal ultrasonography 188
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. 182
Extension of lymphadenectomy for gastric cancer:Audit at European specialist centres. 181
The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours 175
Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy 171
Methylation Dynamics of RASSF1A and Its Impact on Cancer 170
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 170
Acute bleeding obstruction pancreatitis after Roux-en-Y anastomosis in total gastrectomy: a single center experience 163
Clinical pathways in gastric cancer care 159
Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience 157
ASO Author Reflections: Recurrence After Pathological Complete Response in Esophageal Cancer: Analysis of Risk Factors for this Unexpected Event 157
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 155
A national survey on the current status of minimally invasive gastric practice on behalf of GIRCG 151
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? 151
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 151
One stage or two stage treatment of colorectal cancer associated to abdominal aortic aneurysm: morbidity and mortality. 150
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 148
Lymphadenectomy for gastric cancer at European specialist centres 144
Short-term and long-term risk factors in gastric cancer 142
Western strategy for EGJ carcinoma 141
Management of critically ill surgical patients Case reports 138
Is there any role for super-extended limphadenectomy in advanced gastric cancer? results of an observational study from a western high volume center 138
Complications after gastrectomy for cancer: Italian perspective 136
Do all the European surgeons perform the same D2? The need of D2 audit in Europe 135
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne 133
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively 133
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma 131
Multicenter Study of Presentation, Management, and Postoperative and Long-Term Outcomes of Septegenerians and Octogenerians Undergoing Gastrectomy for Gastric Cancer 131
Tailored treatment for signet ring cell gastric cancer 128
Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study 126
Lymphadenectomy: how to do it? 125
Gastric stump cancer after distal gastrectomy for benign disease: clinicopathological features and surgical outcomes. 124
Current practice on the use of prophylactic drain after gastrectomy in Italy: the Abdominal Drain in Gastrectomy (ADiGe) survey 123
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance 123
A therapeutic perspective for proliferative vitreoretinopathy based on the inhibition of epithelial-mesenchymal transition by miR-194 122
Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) Experience 118
Personalized therapeutic strategies in HER2-driven gastric cancer 118
Perianastomotic drainage in Ivor-Lewis esophagectomy, does habit affect utility? An 11-year single-center experience 115
Clinical Features of Gastric Signet Ring Cell Cancer: Results from a Systematic Review and Meta-Analysis 111
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study 111
ASO Visual Abstract: Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 110
Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives 110
Laparoscopic transhiatal suture and gastric valve as a safe and feasible treatment for Boerhaave's syndrome: an Italian single center case series study 109
Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 108
A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits 107
An aggressive early gastric cancer: Kodama's PenA type 107
Clinical predictors of postoperative complications in the context of enhanced recovery (ERAS) in patients with esophageal and gastric cancer 106
Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer 105
Consequences of the COVID-19 pandemic on the diagnosis and treatment of gastric cancer in referral centers in Italy 105
Stage IV Gastric Cancer: The Surgical Perspective of the Italian Research Group on Gastric Cancer 102
VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment 102
Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer 99
Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition 99
Surgical treatment of hepatic metastases from gastric cancer 98
Robotic versus open Ivor-Lewis esophagectomy: A more accurate lymph node dissection without burdening the leak rate 96
Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series 94
Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study 94
Beyond years: evaluating the impact of surgeon age on outcomes after gastric cancer surgery 92
Influence of Tumor Stroma on the Aggressiveness of Poorly Cohesive Gastric Carcinoma 91
Which gastric cancer patients could benefit from staging laparoscopy? A GIRCG multicenter cohort study 90
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape 87
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer 87
Genomic events stratifying prognosis of early gastric cancer 86
Turning left or right? A comparative analysis in adenocarcinomas of the esophagogastric junction according to the seventh AJCC TNM classification for cancers of the esophagus and stomach: experience in a Chinese single institution 86
Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial 86
Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancer 85
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer 84
Treatment of EGJ Cancer within or outside clinical trials: Does the setting matter? A monocentric prospective observational study 81
Looking for a strategy in treating peritoneal gastric cancer carcinomatosis: an Italian multicenter Gastric Cancer Research group's analysis 81
Management, short and long-term outcomes in septegenerians and octegenerians undergoing gastrectomy for cancer 79
A pragmatic approach improves the clinical management of stage IV gastric cancer: Comparison between the Meta-Gastro results and the GIRCG's retrospective series 78
Reconstruction Techniques and Associated Morbidity in Minimally Invasive Gastrectomy for Cancer: Insights From the GastroBenchmark and GASTRODATA databases 77
Palliation with a multimodality treatment including hypoxic pelvic perfusion for unresectable recurrent rectal cancer: outcomes based on a retrospective study 77
Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer 66
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe 66
The hERG1 Potassium Channel Behaves As Prognostic Factor In Gastric Dysplasia Endoscopic Samples 65
Validating a nodal regression system for gastric cancer: An ancillary cohort study of the GASTRODOC trial 65
Unveiling the prognostic significance of malignant ascites in advanced gastrointestinal cancers: a marker of peritoneal carcinomatosis burden 64
Development and validation of pretreatment nomogram for disease-specific mortality in gastric cancer-A competing risk analysis 64
Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe 62
On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer 58
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape : Bertinoro Workshop, November 2022 57
Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice 56
Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas 55
European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4) 54
Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab 53
Prophylactic Total Gastrectomy: Techniques 53
Perioperative Outcomes in Open Versus Minimally Invasive Gastrectomy For Gastric Cancer: A European Multicenter Study Based on the GASTRODATA Registry 52
Defining benchmarks for total and distal gastrectomy: global multicentre analysis 47
Association between ERAS protocol and major postoperative complications and reasons for non-compliance in patients with esophageal cancer 45
Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric Cancer 43
International External Validation of Risk Prediction Model of 90-Day Mortality after Gastrectomy for Cancer Using Machine Learning 40
Upper Gastrointestinal Bleeding 38
Textbook Neoadjuvant Outcome-Novel Composite Measure of Oncological Outcomes among Gastric Cancer Patients Undergoing Multimodal Treatment 31
Impact of postoperative complications on clinical outcomes after gastrectomy for cancer: multicentre study 16
Totale 10.601
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.181
article - articoli 37.851
book - libri 0
conference - conferenze 424
curatela - curatele 0
other - altro 590
patent - brevetti 0
selected - selezionate 0
volume - volumi 316
Totale 78.362
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021206 0 0 0 0 0 47 4 5 21 10 66 53
2021/2022534 25 120 26 42 33 23 8 41 18 30 30 138
2022/20231.276 73 140 102 217 105 319 7 104 129 11 32 37
2023/2024848 17 58 57 97 65 168 40 47 16 75 151 57
2024/20252.055 94 97 93 343 103 69 163 123 279 172 164 355
2025/20264.345 414 326 428 1.200 1.736 241 0 0 0 0 0 0
Totale 10.601